IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659 | +15.9% | 36,578 | +4.8% | 0.01% | +10.0% |
| Q2 2023 | $1,432 | +1.7% | 34,903 | -11.4% | 0.01% | +11.1% |
| Q1 2023 | $1,408 | -2.9% | 39,383 | +2.6% | 0.01% | -18.2% |
| Q4 2022 | $1,450 | -99.9% | 38,378 | -8.3% | 0.01% | -15.4% |
| Q3 2022 | $1,851,000 | +146.8% | 41,844 | +106.5% | 0.01% | +160.0% |
| Q2 2022 | $750,000 | -22.8% | 20,265 | -22.7% | 0.01% | 0.0% |
| Q1 2022 | $971,000 | +30.5% | 26,212 | +7.2% | 0.01% | +66.7% |
| Q4 2021 | $744,000 | +12.2% | 24,454 | +23.8% | 0.00% | -25.0% |
| Q3 2021 | $663,000 | -5.2% | 19,760 | +12.8% | 0.00% | 0.0% |
| Q2 2021 | $699,000 | -44.4% | 17,518 | -37.3% | 0.00% | -42.9% |
| Q1 2021 | $1,257,000 | -13.9% | 27,956 | +8.2% | 0.01% | -22.2% |
| Q4 2020 | $1,460,000 | +36.3% | 25,829 | +14.4% | 0.01% | +28.6% |
| Q3 2020 | $1,071,000 | -0.9% | 22,579 | +23.2% | 0.01% | -22.2% |
| Q2 2020 | $1,081,000 | +47.3% | 18,331 | +18.0% | 0.01% | +12.5% |
| Q1 2020 | $734,000 | -84.1% | 15,529 | -79.7% | 0.01% | -77.8% |
| Q4 2019 | $4,613,000 | +389.7% | 76,358 | +385.5% | 0.04% | +350.0% |
| Q3 2019 | $942,000 | -25.0% | 15,729 | -19.5% | 0.01% | -20.0% |
| Q2 2019 | $1,256,000 | +64.8% | 19,543 | +32.2% | 0.01% | +100.0% |
| Q3 2018 | $762,000 | -27.8% | 14,779 | -41.6% | 0.01% | -28.6% |
| Q2 2018 | $1,055,000 | -13.2% | 25,310 | -8.2% | 0.01% | -12.5% |
| Q1 2018 | $1,215,000 | -42.6% | 27,561 | -34.5% | 0.01% | -42.9% |
| Q4 2017 | $2,117,000 | +307.1% | 42,084 | +310.5% | 0.01% | +366.7% |
| Q3 2017 | $520,000 | +5.7% | 10,252 | +6.0% | 0.00% | 0.0% |
| Q2 2017 | $492,000 | +27.1% | 9,673 | +0.4% | 0.00% | 0.0% |
| Q1 2017 | $387,000 | -16.4% | 9,630 | -0.6% | 0.00% | 0.0% |
| Q4 2016 | $463,000 | -1.5% | 9,685 | -24.6% | 0.00% | 0.0% |
| Q3 2016 | $470,000 | +135.0% | 12,841 | +49.7% | 0.00% | +200.0% |
| Q2 2016 | $200,000 | -24.5% | 8,577 | +31.1% | 0.00% | -50.0% |
| Q1 2016 | $265,000 | +46.4% | 6,541 | +123.6% | 0.00% | +100.0% |
| Q4 2015 | $181,000 | – | 2,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |